NCT05754333View on ClinicalTrials.gov

A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

December 17, 2024

Study Completion Date

January 16, 2025

Conditions
Intraoperative Ureter VisualizationAbdominolpelvic Surgery
Interventions
DRUG

pudexacianinium chloride

Intravenous

Trial Locations (6)

10029

Icahn School of Medicine at Mount Sinai, New York

32803

AdventHealth Orlando, Orlando

33331

Cleveland Clinic Florida, Weston

33613

Advent Health Tampa, Tampa

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

77030

M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY